Won Joon Yoo Selected Research

Injections

7/2013

Conflict of interest in the assessment of botulinum toxin A injections in patients with cerebral palsy: a systematic review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Won Joon Yoo Research Topics

Disease

9	Pseudarthrosis (Pseudoarthrosis) 09/2019 - 05/2005
8	Congenital Abnormalities (Deformity) 06/2021 - 09/2003
4	Neurofibromatosis 1 (Neurofibromatosis Type I) 12/2016 - 12/2008
3	Developmental Dysplasia of the Hip 01/2020 - 06/2016
3	Legg-Calve-Perthes Disease (Perthes Disease) 09/2013 - 09/2009
3	Cerebral Palsy (Spastic Diplegia) 07/2013 - 12/2008
3	Hamartoma 10/2012 - 12/2008
2	Osteonecrosis (Kienbock's Disease) 01/2020 - 06/2016
2	Coxa Magna 05/2016 - 09/2012
2	Foot Deformities (Foot Deformity) 06/2015 - 03/2011
2	Cicatrix (Scar) 09/2010 - 10/2009
2	Postoperative Pain 09/2010 - 07/2010
1	Coxa Valga 01/2022
1	Arthrogryposis 01/2020
1	Hip Dislocation 01/2020
1	Neuromuscular Diseases (Neuromuscular Disease) 01/2020
1	Equinus Deformity 06/2015
1	Pain (Aches) 12/2014
1	Spontaneous Fractures (Pathological Fracture) 03/2014
1	Necrosis 07/2013
1	Type V Osteogenesis Imperfecta 08/2012
1	Femoracetabular Impingement 09/2011
1	Pigmented Villonodular Synovitis 09/2009
1	Slipped Capital Femoral Epiphyses 09/2009
1	Multiple Hereditary Exostoses (Hereditary Multiple Exostoses) 09/2009
1	Postoperative Hemorrhage 09/2009
1	Osteoid Osteoma 09/2009
1	Rare Diseases (Rare Disease) 12/2008
1	Synostosis 07/2006
1	Bone Resorption 09/2005
1	Osteogenesis Imperfecta (Lobstein Disease) 09/2005
1	Melorheostosis 09/2003

Drug/Important Bio-Agent (IBA)

6	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 12/2016 - 12/2007
2	OsteocalcinIBA 09/2011 - 12/2008
2	Messenger RNA (mRNA)IBA 09/2011 - 12/2008
1	Contrast MediaIBA 05/2016
1	Dihydrotachysterol (AT 10)IBA 06/2015
1	ORALIT (ORS)IBA 12/2014
1	MetalsIBA 01/2014
1	di-beta-(morpholinoethyl)selenide (MOSE)IBA 09/2013
1	Type A Botulinum Toxins (Botox)FDA Link 07/2013
1	Genetic Markers (Genetic Marker)IBA 10/2012
1	Fluconazole (Zonal)FDA LinkGeneric 09/2012
1	Proteins (Proteins, Gene)FDA Link 08/2012
1	Alkaline PhosphataseIBA 12/2008
1	Biological ProductsIBA 12/2008
1	Collagen Type II (Type II Collagen)IBA 10/2005
1	Ribonucleases (Ribonuclease)IBA 10/2005
1	Aggrecans (Aggrecan)IBA 10/2005
1	CalciumIBA 09/2005
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 09/2005

Therapy/Procedure

14	Osteotomy 01/2022 - 09/2003
4	Distraction Osteogenesis 09/2019 - 12/2007
4	Ilizarov Technique 09/2011 - 09/2003
2	Aftercare (After-Treatment) 01/2020 - 03/2014
2	General Anesthesia 01/2020 - 07/2010
2	Decompression 03/2014 - 09/2009
2	Operative Surgical Procedures 10/2009 - 09/2009
2	Bone Transplantation (Bone Grafting) 09/2009 - 05/2005
1	External Fixators 06/2021
1	Reoperation 06/2015
1	Injections 07/2013
1	Acetabuloplasty 09/2012
1	Tendon Transfer 03/2011
1	Arthrodesis 03/2011
1	Length of Stay 09/2010
1	Operative Time 09/2009
1	Synovectomy 09/2009
1	Arthroplasty 09/2009